November 2, 2017 / 7:14 AM / 17 days ago

BRIEF-Karo Pharma Q3 EBITDA sharply up yr/yr​

Nov 2 (Reuters) - Karo Pharma Ab

* Says ‍net sales amounted to MSEK 418.9 (250.8), whereof Q3 MSEK 137.1 (85.2)​

* Says ‍EBITDA amounted to MSEK 127.5 (22.8), whereof Q3 MSEK 34.0 (10.2)​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below